Circulation

NOVEMBER 11, 2024

Background:Pulmonary hypertension (PH) is a major contributor to cardiovascular disease-related morbidity and mortality. Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024.

Myocardial Infarction 40

Myocardial Infarction Hospital Hypertension Pulmonary 40

Circulation

NOVEMBER 11, 2024

The primary outcome was a composite of the incidence of myocardial infarction and ischemic and hemorrhagic stroke, obtained by tracking the medical use data of the first-ever ICD-10 codes. HTN elevated the incidence risk of major cardiovascular disease by 2.16 years and median follow-up duration was 15.9

Myocardial Infarction 40

Myocardial Infarction Hypertension Cardiovascular Disease Outcomes 40

The British Journal of Cardiology

JUNE 11, 2024

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).

COVID-19 40

COVID-19 Cardiovascular Disease Angina Chest Pain 40

DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events.

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

DAIC

APRIL 6, 2024

The Minneapolis Heart Institute Foundation (MHIF) is presenting leading research focused on trends in ST-elevation myocardial infarction (STEMI), the most severe form of a heart attack, at the American College of Cardiology’s Annual Scientific Session (ACC.24), 24), being held April 6-8 in Atltanta, GA.

Heart attacks 52

Heart attacks Heart Attack Risk Factors Research 52

Open Heart

MARCH 1, 2024

Introduction Hypertension is the leading modifiable risk factor for cardiovascular disease and is implicated in half of all strokes and myocardial infarctions. One-third of the adults in Scotland have hypertension yet only a quarter of them have their blood pressure (BP) controlled to target (<140/90 mm Hg).

Blood Pressure 40

Blood Pressure Education Hypertension Quality of Life 40

Open Heart

APRIL 6, 2023

Objective American Indians and Alaska Natives (AI/ANs) are an understudied population at high risk for cardiovascular diseases (CVDs); little is known about contextual factors contributing to CVDs in AI/ANs. Coronary heart disease, myocardial infarction and stroke were defined as CVD outcomes.

Myocardial Infarction 40

Myocardial Infarction Diabetes Hypertension Outcomes 40

Dr. Smith's ECG Blog

FEBRUARY 8, 2015

Dilated pupils and hypertension are a strong clue to sympathetic overload, but don't forget anticholinergic syndromes, including tricyclics! I have treated several patients with severe hypertension and tachycardia due to cocaine and/or methamphetamine with a combination of esmolol + nitroprusside or phentolamine. de Lemos, J.

Tachycardia 52

Tachycardia Chest Pain Pharmacology Myocardial Infarction 52

Dr. Smith's ECG Blog

NOVEMBER 30, 2022

This patient, who is a mid 60s female with a history of hypertension, hyperlipidemia and GERD, called 911 because of chest pain. A mid 60s woman with history of hypertension, hyperlipidemia, and GERD called 911 for chest pain. Such cases are classified as MINOCA (Myocardial Infarction with Non-Obstructed Coronary Arteries).

Plaque 52

Plaque Chest Pain Thrombosis Stenosis 52

Frontiers in Cardiovascular Medicine

FEBRUARY 19, 2025

Cardiovascular diseases (CVDs), characterized by a high incidence rate and high mortality, have become the leading cause of death globally. CVDs include coronary heart disease, stroke, hypertension, and peripheral vascular diseases. In China, the death rate of CVDs ranks the first in all major diseases.

Myocardial Infarction 52

Myocardial Infarction Quality of Life Heart Transplant Ischemia 52

Cardiometabolic Health Congress

JANUARY 15, 2025

Atherosclerosisa key driver of cardiovascular disease (CVD)continues to be a significant global health issue. The Hidden Threat: SMuRFless Myocardial Infarctions A concerning trend in CVD is the increase in myocardial infarctions (MI) among individuals without standard modifiable risk factors (SMuRFless MI).

Atherosclerosis 59

Atherosclerosis Plaque Myocardial Infarction Risk Factors 59

Frontiers in Cardiovascular Medicine

JANUARY 22, 2024

This observation has not been investigated in hypertensives of African ancestry. We hypothesised that an individual patient data meta-analysis (IPD-MA) on the efficacy of second- or third-generation beta-blockers (STGBBs) in hypertensives of African descent may provide new insights. 3.00; P < 0.001) in hypertensive Africans.

Blood Pressure 64

Blood Pressure Hypertension Myocardial Infarction Cardiovascular Disease 64

Journal of the American Heart Association

MARCH 13, 2025

The CRHCP (China Rural Hypertension Control Project) trial demonstrated that intensive BP control reduces cardiovascular events. The primary outcome of major adverse cardiovascular events included stroke, myocardial infarction, heart failure, and death from cardiovascular causes, during a 3year followup.

Blood Pressure 45

Blood Pressure Cardiovascular Disease Myocardial Infarction Hypertension 45

European Journal of Heart Failure

DECEMBER 18, 2024

Covariates were adjusted for age (years), pulmonary congestion, percutaneous coronary intervention, left ventricular ejection fraction (%) and hypertension.

Myocardial Infarction 40

Myocardial Infarction BMI Outcomes Heart Failure 40

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

Cardiometabolic Health Congress

JUNE 20, 2024

Dr. Pradeep Natarajan (United States of America) suggested that polygenic risk scores could play a larger role in identifying individuals at risk for cardiovascular disease (CVD). Ultimately, there is an overlap between high-risk primary prevention for cardiovascular disease (CVD) and secondary prevention.

Atherosclerosis 59

Atherosclerosis Cardiovascular Disease Coronary Artery Disease Myocardial Infarction 59

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] 5, 6] So, it seems that once cardiovascular disease is present, then obesity may offer some degree of protection.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Cardiometabolic Health Congress

MAY 10, 2024

The American Heart Association’s scientific statement, “Psychological Health, Well-Being, and the Mind-Heart-Body Connection,” emphasizes the need to evaluate and address psychological health in patients with or at risk for cardiovascular disease (CVD).

Coronary Artery Disease 59

Coronary Artery Disease Obesity Chest Pain Ischemia 59

MIBHS

DECEMBER 13, 2024

Erectile dysfunction (ED) is a common concern among men, especially those dealing with cardiovascular disease. The connection between heart health, vascular risk factors, and sexual function is well-documented, with poor cardiovascular health often leading to or exacerbating erectile issues.

Coronary Artery Bypass Graft 52

Coronary Artery Bypass Graft Diet Heart Disease Risk Factors 52

American College of Cardiology

FEBRUARY 1, 2025

And sex-specific cardiovascular education of trainees and the entire care team is imperative," says Laxmi Mehta, MD, FACC, director of preventive cardiology and women's cardiovascular health at The Ohio State University Wexner Medical Center in Columbus. We need to learn the tools and how to deal with that anxiety well." "In

Cardiovascular Disease 42

Cardiovascular Disease Education Coronary Artery Disease Risk Factors 42

Cardiometabolic Health Congress

DECEMBER 7, 2023

Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD). million.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Strokes 111

Frontiers in Cardiovascular Medicine

APRIL 9, 2025

By quantifying the ratio of left atrial to left ventricular end-diastolic volumes, LACI offers unprecedented prognostic insights into a wide range of cardiovascular diseases, including atrial fibrillation, heart failure, and myocardial infarction, as well as other conditions such as hypertension and cardiomyopathies.

Cardiovascular Disease 52

Cardiovascular Disease Myocardial Infarction Atrial Fibrillation Cardiac Function 52

Cardiometabolic Health Congress

DECEMBER 5, 2024

The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovascular disease prevention and management.

CME 52

CME Obesity Innovation Cardiovascular Disease 52

Open Heart

JANUARY 11, 2025

Background The role of cyclic guanosine 3',5'-monophosphate (cGMP) after acute myocardial infarction (AMI) is not well understood despite its significance as a second messenger of natriuretic peptides (NPs) in cardiovascular disease.

Myocardial Infarction 52

Myocardial Infarction Cardiovascular Disease Hypertension 52

Cardiometabolic Health Congress

NOVEMBER 14, 2024

Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually. 42% of adults are considered obese , increasing their risk of diabetes, hypertension, and cardiovascular issues. Moreover, cardiovascular disease in women continues to be underrepresented and undertreated.

CME 103

CME Obesity Heart Failure Biomarkers 103